Sale!

OSMR Gene Amyloidosis Primary Localized Cutaneous Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The OSMR Gene Amyloidosis Primary Localized Cutaneous Type 1 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, aimed at detecting mutations in the OSMR gene that are associated with Primary Localized Cutaneous Amyloidosis Type 1 (PLCA1). This condition is a rare skin disorder characterized by the deposition of amyloid proteins in the skin, leading to itchy, scaly, or lichenoid eruptions primarily affecting the shins, thighs, feet, and forearms.

The test is pivotal for individuals exhibiting symptoms of PLCA1 or those with a family history of the condition, as it aids in confirming the diagnosis, understanding the risk of transmission to offspring, and guiding management and treatment decisions. By analyzing the genetic makeup of an individual, specifically targeting the OSMR gene, healthcare providers can identify mutations that are known to contribute to the development of this form of amyloidosis.

At DNA Labs UAE, the test is priced at 4400 AED. The process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then examined in the laboratory using advanced genetic sequencing technologies. Results from the test can provide crucial insights into the genetic underpinnings of the disease, allowing for a more targeted approach to treatment and counseling for affected individuals and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

OSMR Gene Amyloidosis primary localized cutaneous type 1 Genetic Test

Test Details

OSMR gene amyloidosis, primary localized cutaneous, type 1 is a rare genetic disorder characterized by the deposition of amyloid protein in the skin. This condition is caused by mutations in the OSMR gene.

Next-generation sequencing (NGS) genetic testing is a diagnostic tool used to identify genetic mutations associated with various diseases, including OSMR gene amyloidosis. NGS allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying genetic variants.

The NGS genetic test for OSMR gene amyloidosis, primary localized cutaneous, type 1 involves obtaining a DNA sample, usually through a blood sample, from the affected individual. The DNA is then sequenced using NGS technology to identify any mutations or genetic variants in the OSMR gene.

The results of the NGS genetic test can help confirm a diagnosis of OSMR gene amyloidosis and provide information about the specific genetic mutation present in the individual. This information can be used to guide treatment decisions and provide genetic counseling to affected individuals and their families.

It’s important to note that genetic testing for OSMR gene amyloidosis, primary localized cutaneous, type 1 may not be available in all healthcare settings. Genetic testing should be performed by a qualified healthcare professional who specializes in genetic disorders.

Test Name

OSMR Gene Amyloidosis primary localized cutaneous type 1 Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Osteology Dermatology Immunology Disorders

Doctor

Dermatologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for OSMR Gene Amyloidosis, primary localized cutaneous, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with OSMR Gene Amyloidosis, primary localized cutaneous, type 1 NGS Genetic DNA Test gene OSMR

Test Name OSMR Gene Amyloidosis primary localized cutaneous type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for OSMR Gene Amyloidosis, primary localized cutaneous, type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with OSMR Gene Amyloidosis, primary localized cutaneous, type 1 NGS Genetic DNA Test gene OSMR
Test Details

OSMR gene amyloidosis, primary localized cutaneous, type 1 is a rare genetic disorder characterized by the deposition of amyloid protein in the skin. This condition is caused by mutations in the OSMR gene.

Next-generation sequencing (NGS) genetic testing is a diagnostic tool used to identify genetic mutations associated with various diseases, including OSMR gene amyloidosis. NGS allows for the simultaneous analysis of multiple genes, making it a powerful tool for identifying genetic variants.

The NGS genetic test for OSMR gene amyloidosis, primary localized cutaneous, type 1 involves obtaining a DNA sample, usually through a blood sample, from the affected individual. The DNA is then sequenced using NGS technology to identify any mutations or genetic variants in the OSMR gene.

The results of the NGS genetic test can help confirm a diagnosis of OSMR gene amyloidosis and provide information about the specific genetic mutation present in the individual. This information can be used to guide treatment decisions and provide genetic counseling to affected individuals and their families.

It’s important to note that genetic testing for OSMR gene amyloidosis, primary localized cutaneous, type 1 may not be available in all healthcare settings. Genetic testing should be performed by a qualified healthcare professional who specializes in genetic disorders.